Seven of eight consumer staples companies beat EPS estimates in Q3 2026 earnings week: Earnings scorecard
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
If I Were In My 30s, I'd Make This 1 Investing Move and Never Look Back
Key PointsIf I could do things over again, I'd save for retirement very differently.
If a Bear Market Is Coming, History Says These Stocks Could Be the Smartest to Own
Consumers don't stop buying vital products during bear markets, which is why healthcare and consumer staples stocks are smart investments.
Is AbbVie a Buy After Its Latest Earnings Report?
Behind a doubling in adjusted EPS sits a more modest picture -- and a dividend streak worth understanding.
- AbbVie's Q3 revenue up 10.3% to $17.4 billion
- Skyrizi and Rinvoq drive 48.7% of total revenue
- AbbVie raises full-year adjusted EPS guidance and dividend
Mastech (MHH) Q3 2026 Earnings Call Transcript
Data and AI bookings surged 29% as bill rates hit record highs.